Terrasym 401
Commercial- Indications
- Soybean yield improvement
Company intelligence / Profile preview
NewLeaf Symbiotics has commercialized a suite of agricultural biological products based on proprietary pink-pigmented facultative methylotrophs (PPFMs). Their EPA-approved TS201 bioinsecticide repels corn rootworm with a novel mode of action and has shown consistent yield advantages. The company also markets biostimulants that improve crop yields across multiple crops. In field trials and early commercialization phases, their technologies have demonstrated reliable performance advantages over standard practices. Ongoing R&D includes new biocontrol agents and solutions targeting nitrogen use efficiency and methane mitigation.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NewLeaf Symbiotics.